CORTLANDT MANOR, N.Y., April 11 /PRNewswire/ -- Polymedco, Inc. is pleased to announce the introduction of the PATHFAST immunoassay analyzer. The PATHFAST rapid point of care system utilizes a chemiluminescent technology combined with a unique magtration separation method that allows this system to report highly accurate results that compare to large platform instruments. The PATHFAST system employs individual cartridge-based technology utilizing a whole blood sample.
The PATHFAST system can handle six samples in batch or random access mode and report these six results in 17 minutes. The PATHFAST analyzer and NTproBNP assay have recently been 510(k) cleared by the FDA. Polymedco has submitted another assay with the FDA and will file three more by the end of April. Polymedco expects to have seven assays cleared by the end of 2008. The initial menu will be related to cardiac proteins, fibrin degradation products, high sensitive c-reactive protein and beta human chorionic gonadotropin.
The PATHFAST system is a small, compact platform, which includes a computer, LCD touch screen and printer and measures W14.7" x D22.4" x H20.0". This self contained unit can easily fit on any laboratory bench. Its user friendly operation allows the technician to simply add blood to the cartridges, place them on the system and press the start button. The technician returns in 17 minutes to read the results. This sensitive technology will allow the laboratory to report NTproBNP results from 15-30,000 pg/mL.
Polymedco, Inc. is a leading manufacturing, marketing and sales company that specializes in bringing innovative equipment and diagnostic kits to the medical market.
For more information, please contact Polymedco at 800-431-2123 or 914-739-5400 or visit our website: www.polymedco.com
SOURCE Polymedco, Inc.
